To explore whether the regulatory process in question is fit for its purpose, the Food & Drug Law Institute’s Food and Drug Policy Forum has published papers by those for and against GE animals, using AquaBounty Technologies’ experiences as a case study.
AquaBounty — whipping boy of the anti-GMO movement — is seeking approval for a genetically engineered Atlantic salmon which grows twice as quickly as standard salmon.
If you are interested in how the FDA determines the safety of genetically engineered (GE) animals for human consumption, here’s some light reading for you.
Read the full story here: GE salmon… Is the FDA’s review process for genetically engineered animals fit for purpose?
Additional Resources:
- Read the Food and Drug Policy Forum papers here (PDF)
- “Food of the future: can ‘Frankenfish’ survive politics?,” SmartPlanet
- “AquaBounty GE Salmon CEO: ‘The atmosphere is getting very poisonous, but all we can do is present the facts’,” Food Navigator
